Tropomyosin Receptor Kinase (TRK) Degradation Compounds and Methods of Use
Copyright © Targeted News Service 2024
2024-04-30
ALEXANDRIA, Virginia, April 30 -- CULLGEN (SHANGHAI), INC., Shanghai, China has been assigned a patent (No. US 11969472 B2, initially filed April 23, 2021) developed by four inventors Jialiang Wang, Nashville, Tennessee; Xiaoran Han, Shanghai, China; Jing Liu, Oradell, New Jersey; and Liqun Chen, Shanghai, China, for "Tropomyosin receptor kinase (TRK) degradation compounds and methods of use." . . .